These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7629727)

  • 1. Preparation and characterization of fibrinogen-coated, reversibly adhesive, lecithin/cholesterol vesicles.
    DeAnglis AP; Retzinger GS
    J Pharm Sci; 1995 Apr; 84(4):399-403. PubMed ID: 7629727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen C-terminal peptidic sequences (Haptides) modulate fibrin polymerization.
    Marx G; Ben-Moshe M; Magdassi S; Gorodetsky R
    Thromb Haemost; 2004 Jan; 91(1):43-51. PubMed ID: 14691567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adsorption of fibrinogen to droplets of liquid hydrophobic phases. Functionality of the bound protein and biological implications.
    Retzinger GS; DeAnglis AP; Patuto SJ
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1948-57. PubMed ID: 9848889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
    Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
    Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of plasma factor XIIIa activity using fibrin-coated microscopic latex beads.
    Retzinger GS; Cook BC; Smith RE; McGinnis MC
    Anal Biochem; 1991 May; 195(1):18-23. PubMed ID: 1679613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Lipid Surface Composition on the Formation and Structure of Fibrin Clots.
    Bakirova DR; Faizullin DA; Valiullina YA; Salnikov VV; Zuev YF
    Bull Exp Biol Med; 2017 Oct; 163(6):722-725. PubMed ID: 29063338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled preparation of thin fibrin films immobilized at solid surfaces.
    Riedel T; Brynda E; Dyr JE; Houska M
    J Biomed Mater Res A; 2009 Feb; 88(2):437-47. PubMed ID: 18306296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct observation of platelet adhesion to fibrinogen- and fibrin-coated surfaces.
    Jen CJ; Lin JS
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1457-63. PubMed ID: 1951733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion.
    Owaynat H; Yermolenko IS; Turaga R; Lishko VK; Sheller MR; Ugarova TP
    Thromb Res; 2015 Dec; 136(6):1231-9. PubMed ID: 26482763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of surface chemistry on adsorbed fibrinogen conformation, orientation, fiber formation and platelet adhesion.
    Zhang L; Casey B; Galanakis DK; Marmorat C; Skoog S; Vorvolakos K; Simon M; Rafailovich MH
    Acta Biomater; 2017 May; 54():164-174. PubMed ID: 28263863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ; Shih MH; Tsai PJ
    Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorption and coagulability of fibrinogen on atheromatous lipid surfaces.
    Retzinger GS
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):786-92. PubMed ID: 7773735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assembly of nonadhesive fibrinogen matrices depends on the αC regions of the fibrinogen molecule.
    Yermolenko IS; Gorkun OV; Fuhrmann A; Podolnikova NP; Lishko VK; Oshkadyerov SP; Lord ST; Ros R; Ugarova TP
    J Biol Chem; 2012 Dec; 287(50):41979-90. PubMed ID: 23086938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bound thrombin from crushed clots is composed of alpha-thrombin and the N-terminal regions of alpha- and gamma-chains of fibrinogen.
    Kinjoh K; Nakamura M; Gang Z; Sunagawa M; Eguchi Y; Kosugi T
    Pathophysiol Haemost Thromb; 2002; 32(4):165-73. PubMed ID: 12759517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
    Maurer MC; Trumbo TA; Isetti G; Turner BT
    Arch Biochem Biophys; 2006 Jan; 445(1):36-45. PubMed ID: 16364233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.